ReviewDiabetology & metabolic syndrome2025

Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Asma Mousavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.